Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics

NCT00668395 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
73
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Indiana University